Search Orphan Drug Designations and Approvals
-
Generic Name: | Small molecule inhibitor of PRMT5 (protein arginine methyl transferase 5) |
---|---|
Date Designated: | 12/05/2022 |
Orphan Designation: | Treatment of malignant glioma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Tango Therapeutics, Inc. 201 Brookline Avenue, Suite 901 Boston, Massachusetts 02115 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-